Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
An Open-Label Phase ½ Study of INCB039110 in Combination With Ibrutinib in Subjects with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.